Metropolis (METROPOLIS) | Stock Overview & Key Data
Metropolis Performance Comparison
Stock Range
Today's Range
Low: ₹1,978.30
High: ₹2,030.00
on August 8, 2025
52 Week Range
Low: ₹1,315.00
High: ₹2,318.30
on April 7, 2025
on October 10, 2024
All-Time High: ₹3,579.90 on December 27, 2021
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR103.3B
EPS
28.16
P/E Ratio (TTM)
70.83
Forward P/E
41.70
P/B Ratio
7.76
PEG Ratio
5.29
Div. Yield
N/A
ROE
11.96%
Beta
0.089
Debt to Equity
15.30
Financial Highlights
Profitability
Gross Margin
78.69%
Operating Margin
10.14%
Profit Margin
10.89%
Returns and Earnings
Return on Assets (TTM)
7.15%
Return on Equity (TTM)
11.96%
EBITDA
INR3.2B
Net Income (TTM)
INR1.4B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR256.99
Quarterly Revenue Growth (YoY)
4.30%
Quarterly Earnings Growth (YoY)
-20.00%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Metropolis METROPOLIS | 103.34B Mid-cap | -1.44% | 7.63% | 20.76% | 11.75% | -2.34% | -2.41% | 35.43% | 19.95% |
| Syngene SYNGENE | 280.43B Large-cap | -6.83% | 3.58% | 7.29% | -11.01% | -25.48% | -22.04% | 10.74% | 31.92% |
| Dr. Lal PathLabs LALPATHLAB | 268.13B Large-cap | 0.41% | 10.77% | 14.95% | 15.06% | 4.50% | -0.66% | 30.89% | 71.26% |
| Sai Life Sciences SAILIFE | 165.96B Mid-cap | 5.06% | 5.26% | 17.03% | 15.41% | 9.22% | 17.66% | 17.66% | 17.66% |
| Vijaya Diagnostic VIJAYA | 110.12B Mid-cap | -2.67% | 5.23% | 5.45% | -3.97% | -0.79% | 27.14% | 196.35% | 68.17% |
| Thyrocare THYROCARE | 71.34B Mid-cap | 1.26% | 25.18% | 47.77% | 71.98% | 45.08% | 65.86% | 115.09% | 89.72% |
Ownership & Short Interest
Insider Ownership
49.89%
Institutional Ownership
42.53%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
77K
Average 90-Day Volume
229K
Metropolis Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Metropolis would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is METROPOLIS's 52-week high and low?
- In the last 52 weeks, Metropolis reached a high of ₹2,318.30 (on October 10, 2024) and a low of ₹1,315.00 (on April 7, 2025).
- What is the market cap and P/E ratio for METROPOLIS?
- Curious about Metropolis's size and valuation? Its market capitalization stands at 103.34B. When it comes to valuation, the P/E ratio (trailing twelve months) is 70.83, and the forward P/E (looking ahead) is 41.70.
- Does METROPOLIS pay dividends? If so, what's the yield?
- As for dividends, Metropolis isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Metropolis's main competitors or similar companies to consider before investing?
When looking at Metropolis, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Syngene
SYNGENE280.43B Healthcare Diagnostics & Research -22.04% 10.74% Dr. Lal PathLabs
LALPATHLAB268.13B Healthcare Diagnostics & Research -0.66% 30.89% Sai Life Sciences
SAILIFE165.96B Healthcare Diagnostics & Research 17.66% 17.66% Vijaya Diagnostic
VIJAYA110.12B Healthcare Diagnostics & Research 27.14% 196.35% Thyrocare
THYROCARE71.34B Healthcare Diagnostics & Research 65.86% 115.09% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Metropolis Healthcare Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Metropolis's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 11.96%, the Debt to Equity ratio from the most recent quarter is 15.30, and its Gross Profit Margin stands at 78.69%.
- What is the recent revenue and earnings growth for METROPOLIS?
- Looking at Metropolis's growth, its revenue over the trailing twelve months (TTM) was INR13B. Compared to the same quarter last year (YoY), quarterly revenue grew by 4.30%, and quarterly earnings saw a YoY growth of -20.00%.
- How much of METROPOLIS stock is held by insiders and institutions?
- Wondering who owns Metropolis stock? Company insiders (like executives and directors) hold about 49.89% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 42.53%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.